Get started Log in

IMMNOV — Immunovia AB (publ) Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
SEK61.82m
Enterprise Value
SEK30.19m
Revenue
SEK0.69m

Brief: Immunovia: Positive Results From Model-Development Study
22/04/2024 07:34
Brief: Immunovia Q4 Revenue SEK 155 Thousand
21/02/2024 07:30
Brief: Immunovia Q3 Net Loss Widens To SEK 38.6 Mln
09/11/2023 08:49
Brief: Immunovia Expects To Announce Research Partnerships In Q1 2024
09/11/2023 07:39
Brief: Immunovia Q3 Adjusted EPS SEK -0.91
09/11/2023 07:34
Brief: Immunovia To Significantly Restructure To Focus Resources On Its Next-Generation Blood Test For Pancreatic Cancer Detection
11/07/2023 21:40
Brief: Jeff Borcherding, CEO Of Immunovia, Purchases 350 000 Shares
09/06/2023 10:04
Brief: Immunovia Sees Modest Revenue Growth For 2023
23/05/2023 08:27
Brief: Immunovia Q1 Adj. EPS at SEK -2.28
23/05/2023 07:31
Brief: Immunovia AB Appoints Jeff Borcherding As New CEO
29/04/2023 15:48
Brief: Immunovia Announces Outcome Of Rights Issue
13/04/2023 07:21
Brief: Immunovia Q4 Net Sales Amounted To SEK 502,000
23/02/2023 07:41
Brief: Immunovia Q4 Net Loss SEK 67 Million
23/02/2023 07:32
Brief: Immunovia Resolves On Rights Issue Of About SEK 202.2 Million
20/02/2023 07:16
Brief: Immunovia Initiates Consultation Process With Relevant Swedish Unions To Create Best Possible Transition For Affected Employees
19/01/2023 07:35
Brief: CMS Sets Rate Of $897 For Immunovia's Immray Pancan-D Test
30/11/2022 08:54
Brief: Immunovia CEO Buys Company Warrants
16/11/2022 07:38
Brief: Immunovia Q3 Net Loss Narrows To SEK 23 Mln
10/11/2022 07:38
Brief: Immunovia Launches Strategic Partnership With Proteomedix
17/10/2022 07:31
Brief: Centers For Medicare & Medicaid Services Issues Preliminary Payment Rate Determination For Immunovia's Immray Pancan-D Test
26/09/2022 10:58